TABLE 1.
Functional NGs applied in theranostic using clinical imaging modalities
| Nanogels composition | Imaging techniques | Contrast agents | Treatments | Therapeutics | Refs. |
|---|---|---|---|---|---|
| MOF@PEG | MRI | MnCo | PTT | PDA | Wang, Wu, et al. (2018) |
| PEI@Fe3O4 | MRI | Fe3O4 | Gene therapy | TFG‐β1 si RNA | Peng et al. (2021) |
| HA‐iodixanol | CT | Iodixanol | Chemotherapy | Paclitaxel | Zhu et al. (2016) |
| HA‐Cisplatin | CT | Cisplatin | Chemotherapy | DOX/cisplatin | Ma, Chen, et al. (2021) |
| MSN@DMAA | US | Perfluorohexane | Chemotherapy | DOX | Qiao et al. (2016) |
| MSN@Fmoc‐Tyr (H2PO3)‐OH | US | Catalase | Chemotherapy | DOX | Wu et al. (2021) |
| PEI‐FA‐PS | MRI/PAI | Gd/CuS | PTT | CuS | Zhang et al. (2020) |
| P(MAA/PEGMA) | PAI/FLI | CuS/Cy‐7 | Chemotherapy/PTT | DOX/CuS | Zhang et al. (2019) |
Abbreviations: DMAA, N,N‐dimethylacrylamide; HA, hyaluronic acid; MOF, metal–organic framework; MSN, mesoporous silica nanoparticles; PDA, polydopamine; PEG, poly(ethylene glycol); PEGMA, poly(ethylene glycol) methacrylate; PEI, poly(ethylenimine); PMAA, poly(methacrylic acid).